The store will not work correctly when cookies are disabled.
5-(3-Naphthalen-1-yl-allylidene)-2-thioxo-dihydropyrimidine-4,6-dione
ID: ALA4164820
PubChem CID: 145959819
Max Phase: Preclinical
Molecular Formula: C17H12N2O2S
Molecular Weight: 308.36
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C1NC(=S)NC(=O)C1=C/C=C/c1cccc2ccccc12
Standard InChI: InChI=1S/C17H12N2O2S/c20-15-14(16(21)19-17(22)18-15)10-4-8-12-7-3-6-11-5-1-2-9-13(11)12/h1-10H,(H2,18,19,20,21,22)/b8-4+
Standard InChI Key: GJNFROAPKWKRER-XBXARRHUSA-N
Molfile:
RDKit 2D
22 24 0 0 0 0 0 0 0 0999 V2000
14.0578 -7.4354 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3500 -7.8429 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.6423 -7.4354 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6423 -6.6163 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3500 -6.2046 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0578 -6.6163 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.9304 -7.8429 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.3500 -5.3896 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.7656 -7.8429 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
11.9304 -6.2046 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2226 -6.6163 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5148 -6.2046 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8029 -6.6163 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8029 -7.4354 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0951 -7.8429 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3874 -7.4354 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3874 -6.6163 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6796 -6.2046 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6796 -5.3896 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3874 -4.9780 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0951 -5.3896 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0951 -6.2046 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
1 6 1 0
3 7 2 0
5 8 2 0
1 9 2 0
10 11 1 0
11 12 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
13 22 2 0
17 22 1 0
12 13 1 0
4 10 2 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 308.36 | Molecular Weight (Monoisotopic): 308.0619 | AlogP: 2.31 | #Rotatable Bonds: 2 |
Polar Surface Area: 58.20 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 7.44 | CX Basic pKa: ┄ | CX LogP: 3.19 | CX LogD: 2.91 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.51 | Np Likeness Score: -0.71 |
References
1. Ramisetti SR, Pandey MK, Lee SY, Karelia D, Narayan S, Amin S, Sharma AK.. (2018) Design and synthesis of novel thiobarbituric acid derivatives targeting both wild-type and BRAF-mutated melanoma cells., 143 [PMID:29133035] [10.1016/j.ejmech.2017.11.006] |